[ad_1]
Total income increased to ₹833 crore for the third quarter of the current fiscal as compared with ₹826 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.
[ad_2]
Source link
GlaxoSmithKline Pharma q3 net declines 72%
